Abstract: Process for continuous inoculation of a food product, in particular a dairy product, with ferments, wherein: frozen concentrated ferments are thawed by means of a microwave device or a water bath thawing device acting on a container containing frozen concentrated ferments, the thawed concentrated ferments are container continuously injected, from the container, into a flow of liquid to be inoculated.
Type:
Application
Filed:
November 29, 2013
Publication date:
December 24, 2015
Applicant:
Chr. Hansen A/S
Inventors:
Jean-Paul POIGNAND, Pascal LANCIAUX, Marion PIQUET, Emilien LANGEVIN, Gilles DIDELOT, Jean-Marie ODINOT, Marc FAIVELEY
Abstract: A method for making a milk product (e.g. a yogurt) comprising adding an effective amount of an N-linked glycosidase and/or an O-linked glycosidase to milk.
Type:
Grant
Filed:
November 23, 2011
Date of Patent:
November 17, 2015
Assignee:
Chr. Hansen A/S
Inventors:
Jonas Jacobsen, Sandra Lykke Wind, Karsten Bruun Qvist
Abstract: The present invention relates to a bacterial cell with texturizing property, starter cultures comprising the cell, and dairy products fermented with the starter culture.
Type:
Application
Filed:
May 21, 2015
Publication date:
November 12, 2015
Applicant:
CHR. HANSEN A/S
Inventors:
Thomas JANZEN, Ditte Ellegaard Christiansen
Abstract: A storage stable frozen lactic acid bacteria (LAB) culture that comprises LAB that are that are able to utilize sucrose, has a weight of at least 50 g frozen material and a content of viable bacteria of at least 109 colony forming units (CFU) per g frozen material.
Type:
Application
Filed:
December 31, 2014
Publication date:
August 13, 2015
Applicant:
CHR. HANSEN A/S
Inventors:
Hans BISGAARD-FRANTZEN, Børge Windel KRINGELUM, Inge KNAP
Abstract: The present invention relates to a process for freeze drying a bacteria-containing concentrate. Further, the present invention relates to the freeze dried concentrates per se.
Type:
Application
Filed:
August 20, 2013
Publication date:
August 6, 2015
Applicant:
Chr. Hansen A/S
Inventors:
Tania Ivanova Georgieva, Anders Clausen, Susanne Abrahamsen, Tina Malling Thorsen
Abstract: The present invention relates to a bacterial cell with texturizing property, starter cultures comprising the cell, and dairy products fermented with the starter culture.
Type:
Grant
Filed:
September 29, 2014
Date of Patent:
June 23, 2015
Assignee:
Chr. Hansen A/S
Inventors:
Thomas Janzen, Ditte Ellegaard Christiansen
Abstract: The present invention is related to the field of reddening of food products. In particular the present invention relates to a two-phase fermentation method for boosting the nitrate reductase activity of Staphylococcus strains with nitrate reductase activity comprising a first aerobic phase in the absence of nitrate and a second anaerobic or oxygen limited phase with continuous nitrate feeding and use of the Staphylococcus strains for reddening of most products.
Abstract: A method for production of an alcoholic beverage with reduced content of alcohol involving treating unfermented beverage starting solution with glucose oxidase and glucose isomerase.
Type:
Grant
Filed:
July 6, 2010
Date of Patent:
May 12, 2015
Assignee:
Chr. Hansen A/S
Inventors:
Johannes Maarten Van Den Brink, Kristine Bjerre
Abstract: An orange/red coloring composition comprising norbixin as an orange/red pigment. Quillaja is present as a dispersing agent. It may be used in the manufacture of food and pharmaceutical products.
Abstract: The present invention relates to a composition comprising Lactobacillus rhamnosus, preferably strain ATCC53103, and Bifidobacterium animalis subsp. lactis, preferably strain DSM 15954, for use in reducing the duration and/or severity of upper respiratory tract infection (URI) in teenagers and adults. Further aspects of the invention relate to a composition comprising Lactobacillus rhamnosus and Bifidobacterium animalis subsp. lactis for use in increasing the Health-Related Quality of Life (HRQL) in teenagers and adults having upper respiratory tract infection (URI), for reducing at least one and preferably several such as two, three, four or all of the symptoms of sore throat, scratchy throat, cough, hoarseness, chest congestion and for reducing the median severity score in teenagers and adults having upper respiratory tract infection (URI).
Abstract: The present invention relates to a bacterial cell with texturizing property, starter cultures comprising the cell, and dairy products fermented with the starter culture.
Type:
Application
Filed:
September 29, 2014
Publication date:
April 9, 2015
Applicant:
CHR. HANSEN A/S
Inventors:
Thomas JANZEN, Ditte Ellegaard CHRISTIANSEN
Abstract: The dairy industry today faces a problem of providing an alternative to adding sweeteners to fermented milk products in order to achieve the desired sweet taste without the added calories. Furthermore, it would be highly advantageous to establish a method for reducing lactose in fermented milk products to a level which is acceptable for lactose-intolerant consumers. The above problems have been solved by providing mutant Streptococcus thermophilus strains and mutant Lactobacillus delbrueckii subsp. bulgaricus strains that excrete glucose to the milk when the milk is inoculated and fermented with such Streptococcus thermophilus strains and Lactobacillus delbrueckii subsp, bulgaricus strains.
Type:
Application
Filed:
April 25, 2013
Publication date:
March 26, 2015
Applicant:
Chr. Hansen A/S
Inventors:
Eric Johansen, Kim Ib Soerensen, Mirjana Curic-Bawden, Mette Pia Junge
Abstract: A Bacillus strain characterized by (i): sensitivity for ampicillin, vancomycin, gentamicin, kanamycin, streptomycin, erythromycin, clindamycin, tetracycline and chloramphenicol; (ii) antimicrobial activity against E. coli and Clostridium perfringens; and (iii) a sporulation percentage of at least 80 when measured after 2 days of incubation. The invention further relates to a method for selecting such strains. Many of the identified strains according to the invention are of the species Bacillus amyloliquefaciens. Some of the Bacillus amyloliquefaciens were further identified as Bacillus amyloliquefaciens subsp. amyloliquefaciens whereas others were identified as amyloliquefaciens subsp. plantarum. A Bacillus strain of the invention may be used as a feed additive to animal feed where it has a probiotic effect.
Type:
Application
Filed:
April 11, 2013
Publication date:
March 19, 2015
Applicant:
Chr. Hansen A/S
Inventors:
Beatrice Nielsen, Mette Dines Cantor, Birgitte Stuer-Lauridsen, Patrick Derkx, Eric Johansen
Abstract: The present invention is related to the field of bioprotection, in particular to the strain of Lactobacillus rhamnosus CHCC5366 with accession no. DSM23035. Furthermore, the present invention concerns an antifungal composition comprising the strain, an antifungal composition comprising the strain and at least one strain of Lactobacillus paracasei, food, feed and pharmaceutical products comprising such an antifungal composition, a method of manufacturing such food, feed and pharmaceutical products, a method for reducing the content of yeasts and molds of such food, feed and pharmaceutical products and uses of the antifungal composition.
Type:
Application
Filed:
April 9, 2013
Publication date:
March 19, 2015
Applicant:
CHR. HANSEN A/S
Inventors:
Tina Hornbaek, Maike Lisberg, Silja Kej Diemer
Abstract: The present invention relates to mutants of lactic acid bacteria which are resistant to the antibiotic ampicillin and which were found to give an increased texture when grown in milk while maintaining the other growth properties of the parent strain. The present invention, furthermore, relates to compositions comprising such mutants, and to dairy products fermented with the lactic acid bacteria resistant to ampicillin.
Type:
Application
Filed:
April 23, 2013
Publication date:
March 19, 2015
Applicant:
Chr. Hansen A/S
Inventors:
Eric Johnsen, Kim Ib Soerensen, Annette Kibenich
Abstract: The present invention is related to the field of bioprotection, in particular to the strain of Lactobacillus paracasei CHCC14676 with accession no. DSM25612. Furthermore, the present invention concerns an antifungal composition comprising the strain, an antifungal composition comprising the strain and at least one strain of Lactobacillus rhamnosus, food, feed and pharmaceutical products comprising such an antifungal composition, a method of manufacturing such food, feed and pharmaceutical products, a method for reducing the content of yeasts and molds of such food, feed and pharmaceutical products and uses of the antifungal composition.
Type:
Application
Filed:
April 9, 2013
Publication date:
March 5, 2015
Applicant:
Chr. Hansen A/S
Inventors:
Tina Hornbaek, Maike Lisberg, Silja Kej Diemer